2.0500
-0.0600
(-2.83%)
As of 2:49:42 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-12,202.0000
-9,139.0000
-8,415.0000
-2,946.0000
-3,511.7720
Investing Cash Flow
76.0000
19,765.0000
-22,094.0000
-1,397.0000
-70.8960
Financing Cash Flow
164.0000
81.0000
220.0000
547.0000
17,340.0650
End Cash Position
11,013.0000
20,562.0000
9,855.0000
40,144.0000
43,939.5120
Capital Expenditure
-32.0000
-366.0000
-2,378.0000
-1,397.0000
-70.8960
Issuance of Capital Stock
164.0000
81.0000
220.0000
547.0000
15,181.7550
Issuance of Debt
--
--
--
--
2,158.3100
Free Cash Flow
-12,234.0000
-9,505.0000
-10,793.0000
-4,343.0000
-3,582.6680
12/31/2020 - 8/12/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATRC AtriCure, Inc.
34.19
+8.85%
EKSO Ekso Bionics Holdings, Inc.
0.7200
-8.75%
MMSI Merit Medical Systems, Inc.
95.61
-0.58%
ANGO AngioDynamics, Inc.
12.43
+1.06%
NEPH Nephros, Inc.
1.4999
-0.01%
PDEX Pro-Dex, Inc.
46.53
-0.94%
HBIO Harvard Bioscience, Inc.
1.8400
-3.16%
NXGL NEXGEL, Inc.
3.5100
+3.54%
AVGR Avinger, Inc.
0.5121
-9.06%
KRMD KORU Medical Systems, Inc.
3.9200
-1.01%